# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 51-60 of 614 results.
PTC-596 in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy
Status: Recruiting
Last Changed: Nov 25, 2019
First Received: Jul 02, 2017
Disease(s): Ovarian Cancer
Intervention(s): PTC596
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer
Status: Not yet recruiting
Last Changed: Feb 26, 2019
First Received: Jan 28, 2019
Disease(s): Ovarian Cancer
Intervention(s): Paclitaxel for injection (albumin-bound)
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Mar 06, 2019
First Received: Feb 03, 2016
Disease(s): Ovarian Cancer
Intervention(s): Hyperthermic intraperitoneal chemotherapy (HIPEC), Carboplatin
Locations: Women's Cancer and Surgical Oncology Center, Loma Linda, California, United States
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Nov 25, 2019
First Received: Nov 25, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): Bevacizumab, Tocotrienol
Locations: Department of Oncology, Vejle Hospital, Vejle, Denmark
Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Aug 01, 2017
First Received: Aug 01, 2017
Disease(s): Ovarian Cancer
Intervention(s): cardiophrenic lymph nodes resection
Locations: Oncology center, Mansoura University, Cairo, Dakhlia, Egypt
Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jul 23, 2018
First Received: Jul 23, 2018
Disease(s): Ovarian Cancer
Intervention(s): Pembrolizumab, Bevacizumab, pegylated liposomal doxorubicin (PLD)
Locations: Gustave Roussy, Villejuif, Val De Marne, France
Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Aug 28, 2019
First Received: Aug 28, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): Tumor Infiltrating Lymphocytes (TIL), Interferon Alfa 2A, Carboplatin, Paclitaxel
Locations: Leiden University Medical Center, Leiden, ZH, Netherlands
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer
Status: Recruiting
Last Changed: Sep 18, 2019
First Received: May 02, 2016
Disease(s): Ovarian Cancer
Locations: Tampere University Hospital, Tampere, Finland
A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
Status: Recruiting
Last Changed: Jan 02, 2020
First Received: Oct 04, 2018
Disease(s): OVARIAN CANCER
Intervention(s): Cobimetinib, Niraparib, Atezolizumab
Locations: University of Arizona Cancer Center, North, Tucson, Arizona, United States
Moores Cancer Center at UC San Diego Health, La Jolla, California, United States
Sutter Health, San Francisco, California, United States
Mayo Clinic-Jacksonville, Jacksonville, Florida, United States
Florida Hospital Cancer Institute; Clinical Research Department, Orlando, Florida, United States
... and 25 other locations.
Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer
Status: Recruiting
Last Changed: May 25, 2018
First Received: Jan 23, 2017
Disease(s): Ovarian Cancer
Intervention(s): Vitamin D3
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States